Fig. 1From: Thymoquinone, piperine, and sorafenib combinations attenuate liver and breast cancers progression: epigenetic and molecular docking approachesInhibitory effect of thymoquinone (TQ), piperine (PIP), and sorafenib (SOR) on the proliferation of HepG2 and MDA-MB-231 cells: Cells were exposed to different concentrations of each compound for 48 hs and cell viability was determined by MTT assayBack to article page